John McGrath, EVP & Chief Financial Officer at Atara Biotherapeutics, Inc. (ATRA), sold 6,000 shares at $41.99 ($242K) on 2018-03-19, disclosed to the SEC on 2018-03-20.
Open-market sale of $242k ATRA by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.99 | 3,000 | $126K | 52.0% |
| 2 | $38.83 | 3,000 | $116K | 48.0% |
| Total | $40.41 avg | 6,000 | $242K | 100% |
| Filing → |
| ATRA | SELL | 2018-01-02 | $640K | — | Filing → |
| ATRA | SELL | 2017-08-17 | $60K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $60K | — | Filing → |